4Alkhateeb A,Fain PR,Thody A,et al.Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families[J].Pigment Cell Res,2003,16(3):208-214.
5Betterle C,Caretto A,De Zio A,et al.Incidence and significance of organ-specific autoimmune disorders (clinical,latent or only autoantibodies) in patients with vitiligo[J].Dermatologica,1985,171(6):419-423.
6Njoo MD,Spuls PI,Bos JD,et al.Nonsurgical repigmentation therapies in vitiligo:meta-analysis of the literature[J].Arch Dermatol,1998,134(12):1532-1540.
7Whitton ME,Ashcroft DM,Barrett CW,et al.Interventions for vitiligo[J].Cochrane Database Syst Rev,2006,25(1):CD003263.
8Hamzavi I,Jain H,McLean D,et al.Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool:the Vitiligo Area Scoring Index[J].Arch Dermatol,2004,140(6):677-683.
9Westerhof W,Nieuweboer-Krobotova L.Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A[J].Arch Dermatol,1997,133(12):1525-1528.
10Njoo MD,Bos JD,Westerhof W.Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy[J].J Am Acad Dermatol,2000,42(2):245-253.
